Product Information
LUMIGAN 0.01% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $103.0828 per ML under NDC 00023320503. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bimatoprost market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.1 mg/mL
Manufacturer
Allergan, Inc.NDC
00023320503
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BIMATOPROSTApproval Type
New Drug (NDA)
FDA Application
NDA022184FDA Approved
8/31/2010
TE Code
AB
On Market Since
9/10/2010
Pharmacological Classes
Price Statistics
The NADAC for LUMIGAN 0.01% EYE DROPS has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 153.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $103.0828 per ML |
|---|---|
| All-time high | $103.2340 (May 13, 2026) |
| All-time low | $40.5079 (Dec 18, 2013) |
| 52-week high | $103.2340 |
| 52-week low | $101.0853 |
| Median price | $79.3513 |
| Average price | $76.0766 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LUMIGAN 0.01% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LUMIGAN 0.01% EYE DROPS, manufactured by Allergan, Inc., is $103.0828 per ML (NDC 00023320503), effective Aug 19, 2026.
How has the price of LUMIGAN 0.01% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LUMIGAN 0.01% EYE DROPS has risen 153.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LUMIGAN 0.01% EYE DROPS?
Since Nov 28, 2013, the NADAC for LUMIGAN 0.01% EYE DROPS has ranged from a low of $40.5079 (Dec 18, 2013) to a high of $103.2340 (May 13, 2026), with a median of $79.3513 per ML.
Are there cheaper alternatives to LUMIGAN 0.01% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LUMIGAN 0.01% EYE DROPS, is $103.0104 per ML — about 0% below LUMIGAN 0.01% EYE DROPS.
Who manufactures LUMIGAN 0.01% EYE DROPS?
LUMIGAN 0.01% EYE DROPS (NDC 00023320503) is labeled by Allergan, Inc., and CMS classifies it as a brand product.